-
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;36:106-16.. pdf -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.
Maiz N, Nicolaides KH.
Fetal Diagn Ther 2010;28:65-71. -
The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis.
Kagan KO, Staboulidou I, Syngelaki A, Cruz JJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:10-4. -
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH.
Obstet Gynecol 2008;112:598-605. -
Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks: effect of plane of acquisition.
Plasencia W, Dagklis T, Pachoumi C, Kolitsi E, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;29:660-5. -
The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact?
Maiz N, Dagklis T, Huggon I, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:813-8. -
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection.
Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, Ding C.
Nat Med 2007;13:218-23. -
Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13(+6) weeks of gestation.
Kagan KO, Frisova V, Nicolaides KH, Spencer K.
Prenat Diagn 2007;27:849-53. -
Ultrasound findings before amniocentesis in selecting the method of analysing the sample.
Kagan KO, Chitty LS, Cicero S, Eleftheriades M, Nicolaides KH.
Prenat Diagn 2007;27:34-9. -
Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6. -
Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC.
Prenat Diagn 2007;27:104-10. -
Nuchal translucency measurements for first-trimester screening: The 'price' of inaccuracy.
Evans MI, Van Decruyes H, Nicolaides KH.
Fetal Diagn Ther 2007;22:401-404. -
Frontomaxillary facial angle in chromosomally normal fetuses at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Kaihura C, Sonek J, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:737-41. -
Predictors of neonatal outcome in early-onset placental dysfunction.
Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Muller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR.
Obstet Gynecol 2007;109:253-61. -
Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;29:51-57. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73.